世界の間質性膀胱炎治療薬市場2023~2027:経口療法、膀胱内療法

■ 英語タイトル:Global Interstitial Cystitis Drugs Market 2023-2027

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR45643-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR45643-23
■ 発行日:2023年1月4日
■ 調査対象地域:北米、ヨーロッパ、アジア、その他地域
■ 産業分野:医薬品
■ ページ数:160
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の間質性膀胱炎治療薬市場2023~2027:経口療法、膀胱内療法]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Technavio社の市場調査レポートによると、世界の間質性膀胱炎治療薬市場は2022年から2027年の間に369.58百万ドルまで展開し、2022年から2027年の間にCAGR 5.9%拡大する見通しです。当調査レポートでは、間質性膀胱炎治療薬の世界市場市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別(経口療法、膀胱内療法)分析、流通チャネル別(病院薬局、小売薬局、オンライン薬局)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、イギリス、ドイツ、日本、中国)分析、成長要因・課題・動向、企業状況、企業分析などの項目を掲載しています。なお、当レポートに記載されている企業情報には、Allergan、Amneal Pharmaceuticals Inc.、Astellas Pharma Inc.、Aurobindo Pharma Ltd.、Bayer AG、Cadila Healthcare Ltd.、Eli Lilly and Co.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界の間質性膀胱炎治療薬市場規模:種類別
- 経口療法における市場規模
- 膀胱内療法における市場規模
・世界の間質性膀胱炎治療薬市場規模:流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- オンライン薬局チャネルの市場規模
・顧客状況
・世界の間質性膀胱炎治療薬市場規模:地域別
- 北米の間質性膀胱炎治療薬市場
- ヨーロッパの間質性膀胱炎治療薬市場
- アジアの間質性膀胱炎治療薬市場
- その他地域の間質性膀胱炎治療薬市場
- アメリカの間質性膀胱炎治療薬市場
- イギリスの間質性膀胱炎治療薬市場
- ドイツの間質性膀胱炎治療薬市場
- 日本の間質性膀胱炎治療薬市場
- 中国の間質性膀胱炎治療薬市場
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主なパラメーターの解析によって得られた、複数の情報源からの情報を、調査・統合・総括することにより、市場の全体像を事細かに提示します。また、主要な業界のインフルエンサーを特定することにより、多様な市場の側面を提供します。これらのデータは包括的​​で信頼性が高く、一次・二次の広範な研究の結果です。Technavio社の市場調査レポートは、確かな市場の成長を推測するための定性的、定量的調査を行い、完全な競争状況、そして詳細なベンダー選択方法と分析を提供します。

間質性膀胱炎治療薬の世界市場 2023-2027

Technavio社は、間質性膀胱炎治療薬市場をモニターしており、2022年から2027年にかけて369.58百万ドルの成長が予測され、予測期間中のCAGRは5.9%で加速すると予測しています。当レポートでは、間質性膀胱炎治療薬市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。間質性膀胱炎の高い有病率、間質性膀胱炎に対する認知度の向上、間質性膀胱炎の研究に対する助成金の増加などが市場を牽引しています。

Technavioの間質性膀胱炎治療薬市場は以下のように区分されています:

・タイプ別:
- 経口療法
- 膀胱内療法

・流通チャネル別:
- 病院薬局
- 小売薬局
- オンライン薬局

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、遺伝子治療の登場が今後数年間の間質性膀胱炎治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、患者支援プログラムや医薬品の承認増加も、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

間質性膀胱炎治療薬市場に関する弊社の調査レポートは以下の分野をカバーしています:
- 間質性膀胱炎治療薬市場のサイジング
- 間質性膀胱炎治療薬市場予測
- 間質性膀胱炎治療薬市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、 Allergan, Amneal Pharmaceuticals Inc., Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, Cadila Healthcare Ltd., Eli Lilly and Co., Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, Kyorin Pharmaceutical Co. Ltd., Mission Pharmacal Co., Perrigo Co. Plc, Pfizer Inc., Purdue Pharma LP, Seikagaku Corp., Sun Pharmaceutical Industries Ltd., Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Incなどの企業情報が含まれています。また、間質性膀胱炎治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global interstitial cystitis drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global interstitial cystitis drugs market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Oral therapy – Market size and forecast 2022-2027
o Exhibit 34: Chart on Oral therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oral therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oral therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oral therapy – Year-over-year growth 2022-2027 (%)
o 6.4 Intravesical therapy – Market size and forecast 2022-2027
o Exhibit 38: Chart on Intravesical therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Intravesical therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Intravesical therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Intravesical therapy – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 43: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 45: Chart on Comparison by Distribution Channel
o Exhibit 46: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacies – Market size and forecast 2022-2027
o Exhibit 47: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o 7.4 Retail pharmacies – Market size and forecast 2022-2027
o Exhibit 51: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacies – Market size and forecast 2022-2027
o Exhibit 55: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 59: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share by geography 2022-2027 (%)
o Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 85: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 Japan – Market size and forecast 2022-2027
o Exhibit 93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 101: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Allergan
o Exhibit 108: Allergan – Overview
o Exhibit 109: Allergan – Product / Service
o Exhibit 110: Allergan – Key offerings
o 12.4 Amneal Pharmaceuticals Inc.
o Exhibit 111: Amneal Pharmaceuticals Inc. – Overview
o Exhibit 112: Amneal Pharmaceuticals Inc. – Business segments
o Exhibit 113: Amneal Pharmaceuticals Inc. – Key news
o Exhibit 114: Amneal Pharmaceuticals Inc. – Key offerings
o Exhibit 115: Amneal Pharmaceuticals Inc. – Segment focus
o 12.5 Astellas Pharma Inc.
o Exhibit 116: Astellas Pharma Inc. – Overview
o Exhibit 117: Astellas Pharma Inc. – Product / Service
o Exhibit 118: Astellas Pharma Inc. – Key offerings
o 12.6 Bayer AG
o Exhibit 119: Bayer AG – Overview
o Exhibit 120: Bayer AG – Business segments
o Exhibit 121: Bayer AG – Key news
o Exhibit 122: Bayer AG – Key offerings
o Exhibit 123: Bayer AG – Segment focus
o 12.7 Cadila Healthcare Ltd.
o Exhibit 124: Cadila Healthcare Ltd. – Overview
o Exhibit 125: Cadila Healthcare Ltd. – Business segments
o Exhibit 126: Cadila Healthcare Ltd. – Key offerings
o Exhibit 127: Cadila Healthcare Ltd. – Segment focus
o 12.8 Eli Lilly and Co.
o Exhibit 128: Eli Lilly and Co. – Overview
o Exhibit 129: Eli Lilly and Co. – Product / Service
o Exhibit 130: Eli Lilly and Co. – Key offerings
o 12.9 Johnson and Johnson
o Exhibit 131: Johnson and Johnson – Overview
o Exhibit 132: Johnson and Johnson – Business segments
o Exhibit 133: Johnson and Johnson – Key news
o Exhibit 134: Johnson and Johnson – Key offerings
o Exhibit 135: Johnson and Johnson – Segment focus
o 12.10 Kyorin Pharmaceutical Co. Ltd.
o Exhibit 136: Kyorin Pharmaceutical Co. Ltd. – Overview
o Exhibit 137: Kyorin Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 138: Kyorin Pharmaceutical Co. Ltd. – Key offerings
o 12.11 Perrigo Co. Plc
o Exhibit 139: Perrigo Co. Plc – Overview
o Exhibit 140: Perrigo Co. Plc – Business segments
o Exhibit 141: Perrigo Co. Plc – Key news
o Exhibit 142: Perrigo Co. Plc – Key offerings
o Exhibit 143: Perrigo Co. Plc – Segment focus
o 12.12 Pfizer Inc.
o Exhibit 144: Pfizer Inc. – Overview
o Exhibit 145: Pfizer Inc. – Product / Service
o Exhibit 146: Pfizer Inc. – Key news
o Exhibit 147: Pfizer Inc. – Key offerings
o 12.13 Seikagaku Corp.
o Exhibit 148: Seikagaku Corp. – Overview
o Exhibit 149: Seikagaku Corp. – Business segments
o Exhibit 150: Seikagaku Corp. – Key offerings
o Exhibit 151: Seikagaku Corp. – Segment focus
o 12.14 Sun Pharmaceutical Industries Ltd.
o Exhibit 152: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 153: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 154: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.15 Taro Pharmaceutical Industries Ltd.
o Exhibit 155: Taro Pharmaceutical Industries Ltd. – Overview
o Exhibit 156: Taro Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 157: Taro Pharmaceutical Industries Ltd. – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 158: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 159: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 161: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 162: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 163: Viatris Inc. – Overview
o Exhibit 164: Viatris Inc. – Business segments
o Exhibit 165: Viatris Inc. – Key offerings
o Exhibit 166: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 167: Inclusions checklist
o Exhibit 168: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 169: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 170: Research methodology
o Exhibit 171: Validation techniques employed for market sizing
o Exhibit 172: Information sources
o 13.5 List of abbreviations
o Exhibit 173: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global interstitial cystitis drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Oral therapy – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral therapy – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral therapy – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral therapy – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Intravesical therapy – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Intravesical therapy – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Intravesical therapy – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Intravesical therapy – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits44: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Distribution Channel
Exhibits46: Data Table on Comparison by Distribution Channel
Exhibits47: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2022-2027 (%)
Exhibits62: Data Table on Market share by geography 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Allergan – Overview
Exhibits109: Allergan – Product / Service
Exhibits110: Allergan – Key offerings
Exhibits111: Amneal Pharmaceuticals Inc. – Overview
Exhibits112: Amneal Pharmaceuticals Inc. – Business segments
Exhibits113: Amneal Pharmaceuticals Inc. – Key news
Exhibits114: Amneal Pharmaceuticals Inc. – Key offerings
Exhibits115: Amneal Pharmaceuticals Inc. – Segment focus
Exhibits116: Astellas Pharma Inc. – Overview
Exhibits117: Astellas Pharma Inc. – Product / Service
Exhibits118: Astellas Pharma Inc. – Key offerings
Exhibits119: Bayer AG – Overview
Exhibits120: Bayer AG – Business segments
Exhibits121: Bayer AG – Key news
Exhibits122: Bayer AG – Key offerings
Exhibits123: Bayer AG – Segment focus
Exhibits124: Cadila Healthcare Ltd. – Overview
Exhibits125: Cadila Healthcare Ltd. – Business segments
Exhibits126: Cadila Healthcare Ltd. – Key offerings
Exhibits127: Cadila Healthcare Ltd. – Segment focus
Exhibits128: Eli Lilly and Co. – Overview
Exhibits129: Eli Lilly and Co. – Product / Service
Exhibits130: Eli Lilly and Co. – Key offerings
Exhibits131: Johnson and Johnson – Overview
Exhibits132: Johnson and Johnson – Business segments
Exhibits133: Johnson and Johnson – Key news
Exhibits134: Johnson and Johnson – Key offerings
Exhibits135: Johnson and Johnson – Segment focus
Exhibits136: Kyorin Pharmaceutical Co. Ltd. – Overview
Exhibits137: Kyorin Pharmaceutical Co. Ltd. – Product / Service
Exhibits138: Kyorin Pharmaceutical Co. Ltd. – Key offerings
Exhibits139: Perrigo Co. Plc – Overview
Exhibits140: Perrigo Co. Plc – Business segments
Exhibits141: Perrigo Co. Plc – Key news
Exhibits142: Perrigo Co. Plc – Key offerings
Exhibits143: Perrigo Co. Plc – Segment focus
Exhibits144: Pfizer Inc. – Overview
Exhibits145: Pfizer Inc. – Product / Service
Exhibits146: Pfizer Inc. – Key news
Exhibits147: Pfizer Inc. – Key offerings
Exhibits148: Seikagaku Corp. – Overview
Exhibits149: Seikagaku Corp. – Business segments
Exhibits150: Seikagaku Corp. – Key offerings
Exhibits151: Seikagaku Corp. – Segment focus
Exhibits152: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits153: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits154: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits155: Taro Pharmaceutical Industries Ltd. – Overview
Exhibits156: Taro Pharmaceutical Industries Ltd. – Product / Service
Exhibits157: Taro Pharmaceutical Industries Ltd. – Key offerings
Exhibits158: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits159: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits160: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits161: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits162: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits163: Viatris Inc. – Overview
Exhibits164: Viatris Inc. – Business segments
Exhibits165: Viatris Inc. – Key offerings
Exhibits166: Viatris Inc. – Segment focus
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR45643-23 )"世界の間質性膀胱炎治療薬市場2023~2027:経口療法、膀胱内療法" (英文:Global Interstitial Cystitis Drugs Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。